Researchers identify two distinct tuberculosis subtypes – one has better prognosis than the other
The study of the human immune response to tuberculosis revealed an approach that can lead to the development of personalized therapies.
Read MoreThe study of the human immune response to tuberculosis revealed an approach that can lead to the development of personalized therapies.
Read MoreIt’s possible that premature cellular aging in TB is one reason why survivors have a three-fold increased risk of mortality.
Read MoreTuberculosis knows no boundaries. It is a life-threatening disease in the United States and around the world – especially for children. Although there has been
Read MoreFor the last three decades Dr. Jeffrey Starke, professor of pediatrics-infectious diseases at Baylor College of Medicine, has spent his career treating children infected with
Read MoreBeyond the ribbon cutting and celebration of opening a new state-of-the-art facility for the Global Tuberculosis Program at Texas Children’s Hospital and Baylor College of
Read More